Gene Query: TAF1D

Dataset Description Geneva Score
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 110.13
Argonaute proteins couple chromatin silencing to alternative splicing 73.47
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 73.47
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 68.08
ETV7 and interferon response 67.33
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 67.33
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 64.22
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 60.72
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 51.42
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 50.48
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 48.43
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 43.16
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 40.43
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 39.73
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 36.72
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 36.72
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 35.8
Alteration of the microRNA network during the progression of Alzheimer’s disease 33.69
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 30.37
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 29.28
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 29.26
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 28.92
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 28.48
Identifying the molecular mode of action of itraconazole in colorectal cancer 27.4
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 24.86
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 24.43
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 24.43
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 24.19
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 24.14
Single-nucleotide-resolution mapping of HBV promoters using CAGE 23.93
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 23.93
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 23.93
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 23.64
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 23.26
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 22.27
Uridylation by TUT4 and TUT7 marks mRNA for degradation 22.16
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 22.08
LncRNA expression profiling of ischemic stroke patients 21.94
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 21.63
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 21.38
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 21.19
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 21.0
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 20.64
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 20.42
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 20.07
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 20.02
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 19.92
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 19.92
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 19.9
Gene expression analysis of immortalized human liver progenitor-like cells in culture 19.74
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 19.58
A sister of NANOG regulates genes expressed in pre-implantation human development 19.5
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 19.39
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 19.38
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 19.37
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 19.31
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 18.87
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 18.73
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 18.67
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 18.58
Regulation of Lipids is Central to Replicative Senescence 18.41
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 18.16
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 18.16
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 18.04
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 17.92
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 17.84
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 17.38
Genes significantly down or Up-regulated upon RNF219 knockdown 17.25
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 16.72
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 16.68
Lysine benzoylation is a novel histone mark [RNA-seq] 16.65
Lysine benzoylation is a novel histone mark 16.65
Differetially expressed genes after hTR overexpression in U2OS cells 16.48
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 16.36
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 16.13
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 16.12
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 15.85
Transcriptomic analysis of human tonsillar TFH subsets 15.71
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 15.13
Rorc disruption in human FG pancreatic cancer cells 15.03
Gene expression analysis of the impact of TDP-43 knockout in human cells. 14.78
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 14.73
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 14.73
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 14.73
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 14.71
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 14.69
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 14.55
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 14.44
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 14.41
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.4
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 14.37
Transcriptome analysis of Zika infected neural stem cells 14.3
Zika infected neural stem cells 14.3
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 14.3
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 14.25
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 14.25
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 14.22
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 14.1
Recovery and analysis of nascent RNA 14.1
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 14.1
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 14.05
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 14.02
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 13.99
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 13.99
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 13.89
3’ Uridylation Expands miRNA Target Repertoire 13.88
Role of microRNAs in the interaction between Salmonella and the host cell 13.77
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 13.73
High-throughput sequencing of PROMPT-enriched samples. 13.71
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 13.63
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 13.56
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 13.56
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 13.49
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 13.48
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 13.38
MRTF activates TEAD-YAP target gene expression 13.36
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 13.35
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 13.35
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 13.34
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 13.34
Disruption of the exocyst induces podocyte loss and dysfunction 13.29
Comprehensive comparative analysis of 5’ end RNA sequencing methods 13.17
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 13.04
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 13.01
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 13.01
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 12.97
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 12.94
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 12.94
hTERT promotes cell adhesion and migration independent of telomerase activity 12.93
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 12.93
Ribosomal footprinting of CN34-Parental and CN34-LM1a 12.86
Dtx3L and Androgen Signaling in Prostate Cancer 12.73
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 12.67
HEXIM1 is induced by DHODH inhibition to suppress melanoma 12.67
Crizotinib v. DMSO in SW480 cells 12.6
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 12.49
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 12.48
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 12.42
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 12.37
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 12.29
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 12.2
Exploring ILF2 regulatory genes by next-generation sequencing 12.19
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 12.16
Profiling of escape kinetics of viruses subjected to RNAi 12.16
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 12.03
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 11.77
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 11.77
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 11.73
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 11.73
hnRNP C is a key regulator of protein synthesis in mitosis 11.73
RNA editing in nascent RNA affects pre-mRNA splicing 11.71
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 11.65
Transcriptomic analysis of the HOTAIR-regulated genes 11.6
Global analysis of enhancer targets: Mosaic-seq 11.54
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 11.53
Primary human trophoblast from term placenta 11.51
Active translatome profiling with RiboLace in MCF7 cells 11.5
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.36
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 11.36
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 11.36
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 11.32
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 11.3
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 11.3
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 11.3
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 11.3
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 11.22
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 11.21
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 11.19
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 11.19
Transcriptional profiling of LS1034 cells treated with tepoxalin 11.17
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 11.14
Gene expression analysis of dengue-infected cells 11.08
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.07
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.04
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 11.0
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 10.99
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 10.94
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.94
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 10.89
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.79
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 10.77
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 10.76
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 10.75
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 10.62
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 10.54
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.44
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 10.36
Genome-wide functional assessment of enhancer activities in the human genome 10.32
CROP-Seq in Primary Human T Cells 10.28
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 10.26
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 10.23
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 10.23
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 10.21
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 10.21
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.18
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.18
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 10.15
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.12
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.04
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 9.98
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 9.95
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 9.95
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.94
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.87
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 9.85
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 9.83
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 9.82
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.81
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 9.81
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 9.8
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 9.78
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 9.75
RNA-Sequencing of HepG2 cells treated with TGFBeta 9.74
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 9.73
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 9.69
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 9.67
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.67
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.65
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.62
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 9.61
Reassessment of Exosome Composition 9.59
RIG-I and MDA5 fRIP during KSHV lytic reactivation 9.58
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 9.57
RNA-seq analysis of uveal melanoma cells treated with FR900359 9.46
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.46
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 9.43
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 9.43
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.37
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 9.31
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 9.31
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.29
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 9.25
Paxillin regulates genomic networks in prostate cancer [PC3] 9.19
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 9.13
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 9.13
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 9.1
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.09
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 9.05
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 8.99
SLIGRL-induced gene expression changes in NHEK cells 8.99
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 8.96
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 8.86
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 8.79
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 8.76
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 8.69
MCF10A H-Ras RNA-Seq 8.67
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.56
IRF2 is a master regulator of human keratinocyte stem cell fate 8.56
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 8.52
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.46
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 8.38
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 8.28
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 8.27
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 8.26
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 8.26
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 8.23
HEK293 Heat-shock experiment 8.22
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 8.22
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 8.06
Co-regulation of splicing by Rbfox1 and hnRNP M 8.06
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 8.03
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 8.0
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.98
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.93
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.92
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 7.9
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 7.88
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.87
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.87
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 7.81
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.78
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.78
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 7.73
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 7.64
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 7.55
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 7.53
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 7.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 7.43
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 7.43
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.39
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 7.35
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 7.35
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 7.34
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.31
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 7.3
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 7.3
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 7.26
RNA-Seq of PRMT1 overexpression ECA109 cells 7.18
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 7.18
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 7.17
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 7.12
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 7.08
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 7.08
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 7.03
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.03
SRSF1 role in cellular gene expression and splicing 6.97
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 6.96
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 6.86
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 6.83
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.82
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 6.79
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.79
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 6.78
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 6.68
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 6.52
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 6.52
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.41
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.39
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.19
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 6.17
RNA sequencing of human mammary epithelial cells 6.1
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 6.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 6.05
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 6.05
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.98
Next generation sequencing of small RNAs isolated from exosomes in human semen 5.94
Molecular Criteria for Defining the Naive Human Pluripotent State 5.94
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.92
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.92
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.89
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.88
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 5.82
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 5.69
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.66
Transcriptome of U251 cells overexpression complement component 7 5.66
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 5.64
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 5.55
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 5.55
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.49
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.46
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 5.44
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 5.44
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 5.4
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 5.39
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.37
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.37
Effect of PRDM11 depletion in U2932 cells 5.37
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 5.37
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.34
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 5.29
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 5.17
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 5.02
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.8
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.78
The contribution of Alu exons to the human proteome 4.68
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 4.6
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 4.58
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 4.57
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 4.57
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 4.56
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 4.56
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 4.49
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.37
Transcriptional responses of melanoma cells to BRAF inhibition 4.37
RNA transcriptome analysis during HSV-1 infection 4.36
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 4.33
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.28
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 4.26
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 4.21
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 4.2
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 4.17
The cohesin release factor WAPL restricts chromatin loop extension. 4.13
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.13
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.08
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.08
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 4.07
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 4.04
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 3.9
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.88
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.87
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 3.82
Determining mRNA half-lives on a transcriptome-wide scale 3.82
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.82
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.77
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 3.62
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.56
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.52
Modulation of nonsense-mediated decay by rapamycin 3.51
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 3.43
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.42
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.41
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 3.39
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.37
Metastasis in triple-negative breast cancer 3.37
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.31
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 3.3
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 3.17
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.16
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 3.15
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.11
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.1
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.99
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.98
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 2.96
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.82
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.78
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.75
O-glcnAc reprograms cellular energetics 2.66
HBEC-shp53-PCHD7 2.66
Transcriptomes of oxLDL exposed trained monocytes 2.62
oxLDL exposed trained monocytes 2.62
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.62
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.61
Gene expression analysis upon mtDNA depletion 2.61
Gene expressions of H9s in different culture systems 2.6
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.54
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.54
Regulatory network controlling tumor-promoting inflammation in human cancers 2.54
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 2.39
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.32
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.32
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.3
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.26
Comparison of microRNA Profiling Platforms (HTS) 2.25
Comparison of microRNA Profiling Platforms 2.25
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.18
CD74 role in transcription regulation [RNA-seq] 2.17
CD74 role in transcription regulation 2.17
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.17
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.03
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.02
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.02
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.0
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.99
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.86
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.84
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.84
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.84
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.81
Finding missing proteins from epigenetically manipulated human cells 1.79
SF3B1 Degron knockdown RNA-seq 1.79
Gene expression analysis of human adenomas. 1.78
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.78
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.74
Gene expression analysis of breast cancer cell-lines 1.74
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 1.64
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.63
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.51
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.43
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.37
Dermal endothelial cells of type 2 diabetic patients 1.26
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.24
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.21
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.16
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.16
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.15
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.09
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.09
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.03
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.03
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.02
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.01
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.95
Human embryonic stem cells in E8 and AKIT culture medium 0.94
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 0.94
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 0.93
Human Treg IL-12 stimulation 0.86
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.82
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.81
Iron response of HepG2 cells 0.78
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.77
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.71
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.62
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.62
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.62
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.61
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.61
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.61
FBXW7 modulates stress response by post-translational modification of HSF1 0.61
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.59
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.53
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.5
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.5
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.5
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.5
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.5
An optimization system for isolating and sequencing of single human colon cancer cells 0.47
The DPYSL2 gene connects mTOR and schizophrenia 0.46
iPSC derived motor neuron cultures from C9ORF72 carriers 0.44
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.43
A code of mono-phosphorylation modulates the function of RB. 0.43
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.4
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.39
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.38
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.38
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 0.37
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.36
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.29
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.29
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.29
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.26
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.26
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.01
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.01
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation